| 000 | 01645 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514041602.0 | ||
| 264 | 0 | _c20030320 | |
| 008 | 200303s 0 0 eng d | ||
| 022 | _a1021-335X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWu, Wenwen | |
| 245 | 0 | 0 |
_aThe intraductal component of breast cancer is poorly responsive to neo-adjuvant chemotherapy. _h[electronic resource] |
| 260 |
_bOncology reports _c |
||
| 300 |
_a1027-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCarcinoma, Intraductal, Noninfiltrating _xdrug therapy |
| 650 | 0 | 4 | _aCell Division |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aDocetaxel |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aIn Situ Nick-End Labeling |
| 650 | 0 | 4 |
_aKi-67 Antigen _xbiosynthesis |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aTaxoids |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKamma, Hiroshi | |
| 700 | 1 | _aUeno, El | |
| 700 | 1 | _aFujiwara, Masachika | |
| 700 | 1 | _aSatoh, Hiroaki | |
| 700 | 1 | _aHara, Hisato | |
| 700 | 1 | _aYashiro, Tohru | |
| 700 | 1 | _aAiyoshi, Yuji | |
| 773 | 0 |
_tOncology reports _gvol. 9 _gno. 5 _gp. 1027-31 |
|
| 999 |
_c12050998 _d12050998 |
||